Several CDC Travel Health Notices this month
June 19, 2026
FFF Enterprises' complete vaccine portfolio provides you with a single source for all respiratory (influenza, COVID-19, RSV), pediatric, adult, and travel vaccine needs. Explore and download our complimentary Respiratory Vaccines Reference Chart and Complete Vaccine Products Reference Guide.
Influenza Vaccines - 2026-27 Trivalent Influenza Vaccines
Start planning for the upcoming flu season by reserving your 2026-27 respiratory vaccines. Reserve influenza vaccines through your BioSupply® account.
According to the Centers for Disease Control & Prevention (CDC), the CDC estimates there were at least 32 million illnesses, 390,000 hospitalizations, and 24,000 deaths related to flu this past season. Help bend the curve of flu-related hospitalizations and deaths this year by planning ahead now.
COVID-19 Vaccines - 2026-27 Season Offerings
View our COVID-19 product page for a complete list. Additionally, FFF now carries the first monoclonal antibody specifically for immunocompromised patients with Invivyd's PEMGARDA® (pemivibart) Injection IgG1λ Monoclonal Antibody (mAb). Prescribing information for PEMGARDA available here.
REMINDER: Although not a vaccine, PEMGARDA® (pemivibart) Injection by Invivyd, Inc. is now available through FFF. The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product PEMGARDA (pemivibart), a SARS-CoV-2 spike protein-directed attachment inhibitor, for the pre-exposure prophylaxis of COVID-19 in adults and adolescents (12 years of age and older weighing at least 40 kg). Prescribing information for PEMGARDA available here.
Respiratory Syncytial Virus (RSV)
Immunizations are recommended by the CDC for infants, some young children, and adults who are older or have certain risk factors that increase severe RSV illness potential. View FFF's RSV vaccine product page.
Travel Vaccines - Vaccine Access
FFF can help keep your patients who are traveling this summer safe with our comprehensive travel vaccine portfolio.
As of June 15, the CDC lists Ituri, Nord-Kivu (North Kivu), and Sud-Kivu (South Kivu) provinces in the Democratic Republic of the Congo (DRC) under its Level 3 Travel Health Notice (THN) due to the ongoing Ebola Bundibugyo virus disease (BVD). Level 3 THNs recommend avoiding nonessential travel to listed locations. Areas in the DRC as well as Uganda that are not experiencing BVD outbreaks are listed as a Level 2 THN, advising travelers to practice enhanced precautions to these regions. Additionally, the CDC added the following areas to its Level 2 THN this month:
- Yemen due to increased cases of malaria (June 11)
- French Guiana due to a chikungunya outbreak (June 4)
- Myotte due to increased cases of malaria (June 2)
The CDC listed the following areas to its Level 1 THN this month, which asks travelers to practice usual precautions: Manitoba, Canada, due to a hepatitis A virus (HAV) outbreak on June 4. Also, areas in Africa (Chad, Guinea, Mali, Mauritania, Niger, Nigeria, Somalia) were added due to outbreaks of diphtheria.
Adult Vaccines - Protecting Patients Against Severe Illness
Take a look at our adult vaccine product page to review our extensive adult vaccines that are in stock and ready to ship today. Visit the CDC for adult immunization schedules. Let FFF help keep your adult patients healthy.
Pediatric Vaccines - For Youth Immunization
Check out the CDC's child immunization schedule. Visit FFF's pediatric vaccines product page for available immunizations.
As a reminder: FFF Enterprises is the exclusive distributor of BabyBIG®, which combats infant botulism. New FDA and CDC reports of recalled powdered infant formula are a reminder of the importance of products like BabyBIG® and the immediate attention this condition requires. View full Prescribing Information.